PDCD1 and melanoma: Moreover, Li et al. developed exosomes carrying PD1 protein and the immune adjuvant imiquimod, displaying the efficient inhibition of PD1/PDL1 immune checkpoint and restored CD8+ T cell function in melanoma and breast cancer models [208].